SCHEMBL5354832

SCHEMBL5354832

Fc1cc(Cl)ccc1C(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.40
CYP3A5 P20815 4/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD11B1 P28845 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
PDK2 Q15119 1/20 0.34
KIF11 P52732 2/20 0.33
SLC6A4 P31645 2/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
TP53 P04637 1/20 0.32
KMO O15229 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3919252 0.82 KIF11 (0.48) CYP3A4CYP3A5TSHRMAPK1TDP1
SCHEMBL30898355 0.82 KIF11 (0.48) CYP3A4CYP3A5TSHRMAPK1TDP1
SCHEMBL28707287 0.80 CYP3A4 (0.46) CYP3A4CYP3A5TSHRMAPK1TDP1
SCHEMBL8156993 0.77 CYP3A4 (0.60) CYP3A4CYP3A5TSHRMAPK1TDP1
SCHEMBL28028709 0.77 CYP3A4 (0.39) CYP3A4TSHRMAPK1TDP1PDK2
SCHEMBL28028710 0.77 CYP3A4 (0.39) CYP3A4TSHRMAPK1TDP1HSD11B1
SCHEMBL1690351 0.76 HDAC3 (0.42) CYP3A4CYP3A5TSHRMAPK1TDP1
SCHEMBL5361521 0.74 CYP11B1 (0.39) CYP3A4KIF11CYP11B1CYP11B2TP53
SCHEMBL298720 0.74 KIF11 (0.50) TSHRMAPK1TDP1KIF11KMT2A
SCHEMBL2795577 0.72 HDAC3 (0.40) CYP3A4CYP3A5TSHRMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169955-B2 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2007-01-30 US disclosed
US-20050113567-A1 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2005-05-26 US disclosed
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE NIHON NOHYAKU CO., LTD. (JP) 2003-10-02 US disclosed
EP-1253128-A1 PERFLUOROISOPROPYLBENZENE DERIVATIVES Nihon Nohyaku Co., Ltd. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE AFF1, CBR1, RER1 CYP3A4 223/4885CYP3A5 281/4885TSHR 232/4885
US-20050113567-A1 Perfluoroisopropylbenzene derivative FFAR3, CBR3, HCAR3 CYP3A4 197/4885CYP3A5 185/4885TSHR 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.